Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells. Others are finding ways to boost the body’s own immune system to attack cancer cells. For the first time, researchers at Penn State have combined the two approaches by conjugating biodegradable polymer nanoparticles encapsulated with chosen cancer-fighting drugs into immune cells to create a smart, targeted system to attack cancers of specific types.
“The traditional way to deliver drugs to tumors is to put the drug inside some type of nanoparticle and inject those particles into the bloodstream,” said Jian Yang, professor of biomedical engineering, Penn State. “Because the particles are so small, if they happen to reach the tumor site they have a chance of penetrating through the blood vessel wall because the vasculature of tumors is usually leaky.”
The odds of interacting with cancer cells can be improved by coating the outside of the nanoparticles with antibodies or certain proteins or peptides that will lock onto the cancer cell when they make contact. However, this is still a passive drug delivery technology. If the particle does not go to the tumor, there is no chance for them to bind and deliver the drug.
Yang and Cheng Dong, department head and distinguished professor of biomedical engineering, wanted a more active method of targeting drugs to the cancer wherever it was located, whether circulating in the blood, or in the brain or in any of the other organs of the body.
“I have 10 years of working in immunology and cancer,” Dong said. “Jian is more a biomaterials scientist. He knows how to make the nanoparticles biodegradable. He knows how to modify the particles with surface chemistry, to decorate them with peptides or antibodies. His material is naturally fluorescent, so you can track the particles at the same time they are delivering the drug, a process called theranostics that combines therapy and diagnostics. On the other hand, I study the cancer microenvironment, and I have discovered that the microenvironment of the tumor generates kinds of inflammatory signals similar to what would happen if you had an infection.”
Immune cells, which were built to respond to inflammatory signals, will be naturally attracted to the tumor site. This makes immune cells a perfect active delivery system for Yang’s nanoparticles. The same technology is also likely to be effective for infectious or other diseases, as well as for tissue regeneration, Dong said.
In the first proof of their technology, the two research groups targeted circulating melanoma cells. In a paper published in the current online issue of the journal Small, titled “Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting,” the researchers report the use of a novel biodegradable and photoluminescent poly (lactic acid) (BPLP-PLA) nanoparticle, loaded with melanoma-specific drugs with immune cells as the nanoparticle carriers. They showed that the immune cells could bind to the melanoma cells under shear stress conditions similar to those in the bloodstream. These experiments were all performed outside the body. Next they intend to perform studies in animal models and in solid tumors.
“This is the first study and is just to show that the technology works,” Dong said. “This study is not about curing melanoma. There are probably other ways to do that. We used melanoma cells to validate the approach.”
Receive an email update when we add a new DRUG DELIVERY article.
The Latest on: Nanoparticle drug delivery
via Google News
The Latest on: Nanoparticle drug delivery
- MGC Pharma gets CDSCO approval to import its nanoparticle micellar formulation, CimetrA for testing to treat Covid-19on September 2, 2021 at 2:00 am
MGC Pharma gets CDSCO approval to import its nanoparticle micellar formulation, CimetrA for testing to treat Covid-19: Our Bureau, New Delhi Thursday, September 2, 2021, 14:30 Hrs ...
- CRISPR-Based Therapeutics Blaze an In Vivo Path to the Clinicon September 1, 2021 at 10:29 am
Pioneering companies are showing that CRISPR systems can be tucked inside delivery vehicles and injected locally or systemically to bring about cures.
- Sorrento pitches lymphatic delivery for COVID-19 vaccine dose sparingon August 31, 2021 at 4:45 am
Developers of the first wave of COVID-19 prophylactics used a range of vaccine technologies but all relied on the same, tried-and-tested vial and syringe administration system. Now, with the pandemic ...
- 3 Current news about the topic particle measurementon August 31, 2021 at 4:41 am
Physicists at Southern Methodist University, Dallas, have achieved a new precise measurement of a key subatomic particle, opening the door to better understanding some of the deepest mysteries of our ...
- Breakthrough in sizing nanoparticles using fluid-filled tubeson August 30, 2021 at 9:31 pm
The functionality of nanoparticles in a host of applications, including drug delivery and nano-optics, is often dictated by their mass and size. Measuring these properties simultaneously for the s ...
- Sizing nanoparticles using fluid-filled tubeson August 24, 2021 at 9:19 am
The functionality of nanoparticles in a host of applications, including drug delivery and nano-optics, is often dictated by their mass and size. Measuring these properties simultaneously for the same ...
- Major discovery in sizing nanoparticles using fluid-filled tubeson August 24, 2021 at 5:49 am
(Nanowerk News) The functionality of nanoparticles in a host of applications, including drug delivery and nano-optics, is often dictated by their mass and size. Measuring these properties ...
- Nanotechnology Could Assist in the Treatment of Respiratory Tract Infectionson August 23, 2021 at 8:23 am
A new review paper looks at the use of nanoparticles in the treatment of respiratory illness. The respiratory tract is frequently exposed to elements in the atmosphere like bacteria, viruses, and even ...
- New Nanoparticle Drug Delivery System for HIV/AIDS Treatmenton August 11, 2021 at 5:00 pm
A biochemistry researcher from the University of Miami Miller School of Medicine has discovered that a nanoparticle drug delivery system can help decrease HIV/AIDS viral reservoirs present in the ...
via Bing News